Literature DB >> 28848812

A Decade of National Heart, Lung, and Blood Institute Programs Supporting COPD Research and Education .

Lisa Postow1, Antonella Punturieri1, Thomas L Croxton1, Gail G Weinmann1, James P Kiley1.   

Abstract

The past decade of research in chronic obstructive pulmonary disease (COPD) has seen a new age of understanding both pathogenic mechanisms and clinical manifestations of the disease. The National Heart, Lung, and Blood Institute (NHLBI) has helped guide this progress with a series of initiatives to stimulate COPD research in various ways. These initiatives were designed to promote a precision medicine approach to treating COPD, one that takes advantage of targeting particular molecular pathways and the individual pathobiologies of the diversity of COPD patients. This review describes the strategic objectives of these initiatives, as well as some of their observed and anticipated outcomes. In addition, we address parallel steps NHLBI has taken to promote COPD awareness among the public. As we look toward the immediate future of COPD research and education, we see a time of great progress in terms of understanding and treatment. Furthermore, while this remains a debilitating and disturbingly prevalent disease, as NHLBI looks even farther ahead, we envision emerging efforts toward COPD prevention.

Entities:  

Keywords:  COPDrequest for applications; National Heart, Lung, and Blood Institute; National Institutes of Health; biomarkers; education; funding opportunity announcement; genomics; initiative; resource grant; subpopulations

Year:  2014        PMID: 28848812      PMCID: PMC5559142          DOI: 10.15326/jcopdf.1.1.2014.0123

Source DB:  PubMed          Journal:  Chronic Obstr Pulm Dis        ISSN: 2372-952X


  26 in total

1.  Future research directions in chronic obstructive pulmonary disease.

Authors:  Thomas L Croxton; Gail G Weinmann; Robert M Senior; John R Hoidal
Journal:  Am J Respir Crit Care Med       Date:  2002-03-15       Impact factor: 21.405

2.  CLINICAL TYPES OF CHRONIC OBSTRUCTIVE LUNG DISEASE IN LONDON AND IN CHICAGO. A STUDY OF ONE HUNDRED PATIENTS.

Authors:  B BURROWS; A H NIDEN; C M FLETCHER; N L JONES
Journal:  Am Rev Respir Dis       Date:  1964-07

3.  Chronic obstructive pulmonary disease among adults--United States, 2011.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2012-11-23       Impact factor: 17.586

4.  Muc5b is required for airway defence.

Authors:  Michelle G Roy; Alessandra Livraghi-Butrico; Ashley A Fletcher; Melissa M McElwee; Scott E Evans; Ryan M Boerner; Samantha N Alexander; Lindsey K Bellinghausen; Alfred S Song; Youlia M Petrova; Michael J Tuvim; Roberto Adachi; Irlanda Romo; Andrea S Bordt; M Gabriela Bowden; Joseph H Sisson; Prescott G Woodruff; David J Thornton; Karine Rousseau; Maria M De la Garza; Seyed J Moghaddam; Harry Karmouty-Quintana; Michael R Blackburn; Scott M Drouin; C William Davis; Kristy A Terrell; Barbara R Grubb; Wanda K O'Neal; Sonia C Flores; Adela Cota-Gomez; Catherine A Lozupone; Jody M Donnelly; Alan M Watson; Corinne E Hennessy; Rebecca C Keith; Ivana V Yang; Lea Barthel; Peter M Henson; William J Janssen; David A Schwartz; Richard C Boucher; Burton F Dickey; Christopher M Evans
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

5.  Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study.

Authors:  N R Anthonisen; J E Connett; J P Kiley; M D Altose; W C Bailey; A S Buist; W A Conway; P L Enright; R E Kanner; P O'Hara
Journal:  JAMA       Date:  1994-11-16       Impact factor: 56.272

6.  Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease.

Authors:  Edy Y Kim; John T Battaile; Anand C Patel; Yingjian You; Eugene Agapov; Mitchell H Grayson; Loralyn A Benoit; Derek E Byers; Yael Alevy; Jennifer Tucker; Suzanne Swanson; Rose Tidwell; Jeffrey W Tyner; Jeffrey D Morton; Mario Castro; Deepika Polineni; G Alexander Patterson; Reto A Schwendener; John D Allard; Gary Peltz; Michael J Holtzman
Journal:  Nat Med       Date:  2008-05-18       Impact factor: 53.440

7.  The relation of circulating YKL-40 to levels and decline of lung function in adult life.

Authors:  Stefano Guerra; Marilyn Halonen; Duane L Sherrill; Claire Venker; Amber Spangenberg; Anne-elie Carsin; Lluïsa Tarès; Iris Lavi; Esther Barreiro; Jesús Martínez-Moratalla; Isabel Urrutia; Jordi Sunyer; Josep M Antó; Fernando D Martinez
Journal:  Respir Med       Date:  2013-08-03       Impact factor: 3.415

8.  Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.

Authors:  Derek E Byers; Jennifer Alexander-Brett; Anand C Patel; Eugene Agapov; Geoffrey Dang-Vu; Xiaohua Jin; Kangyun Wu; Yingjian You; Yael Alevy; Jean-Philippe Girard; Thaddeus S Stappenbeck; G Alexander Patterson; Richard A Pierce; Steven L Brody; Michael J Holtzman
Journal:  J Clin Invest       Date:  2013-08-15       Impact factor: 14.808

9.  Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.

Authors:  Mark T Dransfield; Moon H Nahm; Meilan K Han; Sarah Harnden; Gerard J Criner; Fernando J Martinez; Paul D Scanlon; Prescott G Woodruff; George R Washko; John E Connett; Nicholas R Anthonisen; William C Bailey
Journal:  Am J Respir Crit Care Med       Date:  2009-06-25       Impact factor: 21.405

10.  Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study.

Authors:  Wanda K O'Neal; Wayne Anderson; Patricia V Basta; Elizabeth E Carretta; Claire M Doerschuk; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Jeffrey L Curtis; Meilan K Han; Nadia N Hansel; Richard E Kanner; Eric C Kleerup; Fernando J Martinez; Bruce E Miller; Stephen P Peters; Stephen I Rennard; Mary Beth Scholand; Ruth Tal-Singer; Prescott G Woodruff; David J Couper; Sonia M Davis
Journal:  J Transl Med       Date:  2014-01-08       Impact factor: 5.531

View more
  2 in total

Review 1.  The Launch of a New COPD Journal.

Authors:  James D Crapo; Peter J Barnes; Paul W Jones; Barry J Make; David M Mannino
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

Review 2.  Critical Challenges and Compelling Questions for Chronic Obstructive Pulmonary Disease. Moving the Field Forward: A National Heart, Lung, and Blood Institute Perspective.

Authors:  Lisa Postow
Journal:  Ann Am Thorac Soc       Date:  2018-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.